The work of healthcare supply chain has never been simple, but it continues to become more complex. Leaders must anticipate disruptions, protect clinical capacity, reduce waste, strengthen supplier relationships, and help their organizations respond to financial pressure. Those responsibilities have real consequences. Do clinicians have the products they need? Can procedures remain on schedule? Can the organization continue delivering care safely and efficiently?
That broader role is at the heart of our cover feature, “Beyond Unit Price.” As the title suggests, strategic sourcing can no longer revolve around purchase price alone. Health systems are drawing on market intelligence, clinical input, supply risk data, and deeper supplier partnerships to make better decisions. The feature also makes clear that there is no single answer to the question of consolidation versus diversification. The right approach depends on the product, the market, the available suppliers and, ultimately, the potential effect on patient care.
Associate Editor Matt MacKenzie’s article looks at a very different challenge, but the underlying lesson is much the same. Hospitals cannot wait until a patient with a suspected high-consequence pathogen arrives to determine what they need. Supply chain leaders must identify the necessary PPE, devices, disinfectants, specimen-collection supplies and waste-handling materials in advance. They also need to monitor expiration dates, confirm supplier lead times, and make sure reserved products still align with current clinical protocols.
Preparation is not limited to physical products, either. It also applies to the data and technology supporting medication use. The FDA’s transition to a uniform 12-digit National Drug Code has a March 2033 deadline, which may sound comfortably distant. But NDC data already moves through purchasing, inventory, dispensing, medication administration, billing, and quality reporting. In a conversation with HPN, Vizient’s Carolyn Liptak stressed that health systems should begin establishing enterprise governance, assessing affected workflows, engaging vendors, and developing end-to-end testing strategies now.
These articles take on different subjects, but they arrive at the same conclusion. Supply chain leadership increasingly means seeing what is coming and acting before it becomes urgent. Whether the challenge is strategic sourcing, an emerging pathogen, or a multi-year data transition, readiness depends on visibility, collaboration, and a willingness to start early.
